PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 3 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY Chembio Diagnostics Inc., a subsidiary of BIOSYNEX, receives a grant to develop a rapid point-of-care diagnostic test for congenital syphilis supported by the Bill & Melinda Gates Foundation Grant BIOSYNEX Congenital Syphilis Chembio Diagnostics Inc. Bill & Melinda Gates Foundation
BRIEF published on 10/17/2024 at 18:05, 1 year 3 months ago BIOSYNEX SA: 2024 Half-Year Results and Debt Restructuring Revenue Growth Half-year Results Debt Restructuring Cost Rationalization American Expansions
BRIEF published on 07/18/2024 at 18:05, 1 year 6 months ago BIOSYNEX: Revenue for the first half of 2024 up 26% Acquisitions Growth Turnover Export American Subsidiaries
BRIEF published on 05/28/2024 at 17:50, 1 year 8 months ago BIOSYNEX obtains its first CE markings according to the new IVDR regulations In Vitro Diagnostics BIOSYNEX IVDR CE Marking Rapid Tests
BRIEF published on 05/28/2024 at 17:50, 1 year 8 months ago BIOSYNEX Obtains Its First CE Markings According to IVDR Regulations BIOSYNEX IVDR CE Marking Rapid Tests Molecular Biology
BRIEF published on 05/13/2024 at 20:22, 1 year 8 months ago BIOSYNEX strengthens its governance and promotes new talents Governance Chief Operating Officer ESG BIOSYNEX Health Diagnosis
BRIEF published on 05/13/2024 at 18:05, 1 year 8 months ago BIOSYNEX SA strengthens its governance with new appointments Governance Appointments ESG Health BIOSYNEX
BRIEF published on 05/03/2024 at 18:05, 1 year 8 months ago BIOSYNEX announces its capital indicators for April 2024 Share Capital Voting Rights Financial Regulation BIOSYNEX Markets Financial Regulation
BRIEF published on 04/29/2024 at 08:05, 1 year 9 months ago BIOSYNEX and its subsidiary ProciseDx expand their presence in North America thanks to a new agreement BIOSYNEX Medical Diagnosis ProciseDx EUROIMMUN US Inflammatory Bowel Diseases
BRIEF published on 04/24/2024 at 18:08, 1 year 9 months ago BIOSYNEX announces a drop in results in 2023 but anticipates a recovery for 2025 Profitability Restructuring 2023 Financial Results BIOSYNEX Debt Reorganization
Published on 01/31/2026 at 03:15, 1 day 3 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 4 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 7 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 14 hours 39 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 18 hours 8 minutes ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 3 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 8 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 10 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 17:45, 1 day 12 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 2 days 12 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 2 days 12 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 2 days 12 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
